VOLANTE, Marco
 Distribuzione geografica
Continente #
NA - Nord America 15.754
EU - Europa 10.192
AS - Asia 5.541
SA - Sud America 566
OC - Oceania 216
AF - Africa 180
Continente sconosciuto - Info sul continente non disponibili 23
Totale 32.472
Nazione #
US - Stati Uniti d'America 15.330
CN - Cina 2.838
IT - Italia 2.422
IE - Irlanda 1.035
DE - Germania 1.032
FR - Francia 927
SE - Svezia 813
UA - Ucraina 605
JP - Giappone 589
FI - Finlandia 527
GB - Regno Unito 497
KR - Corea 479
IN - India 468
PL - Polonia 380
AT - Austria 337
BR - Brasile 335
CA - Canada 313
VN - Vietnam 308
ES - Italia 295
TR - Turchia 247
NL - Olanda 201
BE - Belgio 198
AU - Australia 193
DK - Danimarca 135
GR - Grecia 133
RU - Federazione Russa 120
AR - Argentina 103
MX - Messico 94
CH - Svizzera 92
SN - Senegal 88
TW - Taiwan 88
PT - Portogallo 83
SG - Singapore 83
HK - Hong Kong 80
HU - Ungheria 80
RO - Romania 74
IL - Israele 52
CL - Cile 51
CZ - Repubblica Ceca 47
TH - Thailandia 46
CO - Colombia 45
SA - Arabia Saudita 42
NO - Norvegia 37
MY - Malesia 35
ID - Indonesia 34
PH - Filippine 34
DZ - Algeria 30
HR - Croazia 26
RS - Serbia 26
UZ - Uzbekistan 25
PK - Pakistan 23
EU - Europa 22
NZ - Nuova Zelanda 21
SI - Slovenia 20
EC - Ecuador 15
ZA - Sudafrica 14
EG - Egitto 12
PE - Perù 12
IR - Iran 11
SK - Slovacchia (Repubblica Slovacca) 11
BY - Bielorussia 8
JO - Giordania 8
AM - Armenia 7
BG - Bulgaria 7
QA - Qatar 7
AE - Emirati Arabi Uniti 6
IQ - Iraq 6
MA - Marocco 6
NG - Nigeria 6
SD - Sudan 6
BA - Bosnia-Erzegovina 5
MK - Macedonia 5
PR - Porto Rico 5
LT - Lituania 4
VE - Venezuela 4
BD - Bangladesh 3
KE - Kenya 3
KZ - Kazakistan 3
MO - Macao, regione amministrativa speciale della Cina 3
MT - Malta 3
MU - Mauritius 3
OM - Oman 3
PA - Panama 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
CU - Cuba 2
CY - Cipro 2
EE - Estonia 2
FJ - Figi 2
GT - Guatemala 2
LB - Libano 2
RE - Reunion 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
Totale 32.457
Città #
Chandler 1.558
Beijing 1.407
Houston 1.132
Fairfield 1.101
Dublin 1.016
Ashburn 752
Ann Arbor 705
Redwood City 659
Torino 578
Wilmington 574
Woodbridge 568
Seattle 479
Villeurbanne 399
Jacksonville 376
Cambridge 368
Nyköping 335
Pisa 334
Vienna 312
Medford 300
Princeton 300
Dearborn 289
Warsaw 265
Dong Ket 173
Shanghai 169
Boston 156
Tokyo 150
New York 144
Milan 136
Fremont 135
Brussels 132
Guangzhou 126
Nanjing 117
Turin 103
Boardman 98
Hangzhou 96
Würzburg 92
San Diego 84
Pune 79
Chicago 77
Chengdu 73
Munich 69
Toronto 69
Seoul 68
São Paulo 67
Rome 59
Paris 56
Taipei 55
Norwalk 54
Düsseldorf 53
London 52
Madrid 52
Verona 50
Bologna 49
Shenyang 49
Hefei 47
Phoenix 47
Athens 45
Buenos Aires 45
Falls Church 45
Istanbul 44
Santiago 44
Washington 44
Zhengzhou 44
Helsinki 43
Budapest 42
Padova 41
New Delhi 40
Pittsburgh 40
Birmingham 39
Silver Spring 39
Wuhan 39
Ankara 38
Brescia 37
Florence 37
Singapore 37
Bethesda 36
Canberra 36
Kunming 35
Rochester 34
Mountain View 33
Amsterdam 32
Tappahannock 32
Los Angeles 31
Central District 30
Jinan 30
Barcelona 29
Lexington 28
Philadelphia 28
Moscow 27
Berlin 26
Changsha 26
Dallas 26
Hebei 26
Delhi 25
Piemonte 25
Gurgaon 24
Lyon 24
Montréal 24
Oslo 24
Brisbane 23
Totale 18.340
Nome #
The weiss score and beyond--histopathology for adrenocortical carcinoma. 1.361
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 1.001
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology 853
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 627
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 623
Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: Targeted Next Generation Sequencing Suggests a Monoclonal Origin of the Two Components 554
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 495
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. 487
IMPACT OF PREGNANCY ON PROGNOSIS OF DIFFERENTIATED THYROID CANCER: CLINICAL AND MOLECULAR FEATURES. 419
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 405
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 401
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. 400
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma. 394
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart 368
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. 354
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. 353
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 322
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 316
Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma 304
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 301
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 296
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 294
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 291
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION. 289
Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells 284
An exploration of pathways involved in lung carcinoid progression using gene expression profiling 283
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 280
An international Ki67 reproducibility study in adrenal cortical Carcinoma 272
Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. 261
Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. 260
Pathology of the Adrenal Cortex: a Reappraisal of the Past 25 Years Focusing on Adrenal Cortical Tumors. 256
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 256
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 247
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. 244
Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis 243
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 241
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 240
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 233
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 228
MEN1 Gene Mutation and Reduced Expression Are Associated with Poor Prognosis in Pulmonary Carcinoids 222
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 219
Retrospective multicenter study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung 219
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 219
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 215
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC 199
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 198
Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: A case report and review of the literature 188
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 186
Brca1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: a Large Retrospective Study 185
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 179
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 178
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 177
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. 170
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 170
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing 167
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 165
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 162
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin 161
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 161
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 157
Bevacizumab Plus Octreotide and Metronomic Capecitabine in Patients with Metastatic Well-to-Moderately Differentiated Neuroendocrine Tumors. The XELBEVOCT Multicenter Phase II Study 154
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. 152
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. 147
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 134
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 134
Biological role and clinical significance of CD157 in epithelial ovarian cancer 126
Tissue arrays as fiducial markers for section alignment in 3-D reconstruction technology 124
Thymidylate synthase expression in large cell carcinoma ofthe lung 123
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer 122
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 122
Mechanical phenotyping of cells and extracellular matrix as grade and stage markers of lung tumor tissues 120
Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures 119
Biological role, clinical significance and potential therapeutic applications of CD157 in ovarian cancer 118
CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma 118
RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion. 117
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. 116
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 114
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 111
Extensive DNA fragmentation in oxyphilic cell lesions of the thyroid. 109
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer. J Thorac Oncol. 2009 Apr 29 108
Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung 107
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 105
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine 104
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma 104
Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies. 103
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung 103
Clinical and biological significance of CD157 in malignant pleural mesothelioma 103
Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation 103
CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study 103
Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases 102
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 100
CD157 is a novel prognostic marker of malignant pleural mesothelioma involved in the control of tumor aggressiveness 99
Absence of gene mutations in a case of concomitant presence of carcinoid of the ampulla of vater pheochromocytoma and Von Recklinghausen disease 98
Valutazione prospettica di pazienti operati radicalmente per carcinoma corticosurrenalico in trattamento con mitotane adiuvante: correlazioni tra indici di massa corporea, livelli di mitotanemia ed efficacia. 98
A prospective study on adjuvant mitotane 96
99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression 95
Cytology of Primary Salivary Gland-Type Tumors of the Lower Respiratory Tract: Report of 15 Cases and Review of the Literature 94
Androgen deprivation modulates gene expression profile along prostate cancer progression 94
IκBα targeting promotes oxidative stress-dependent cell death 93
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network 92
Totale 23.717
Categoria #
all - tutte 74.195
article - articoli 0
book - libri 0
conference - conferenze 6.160
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.355


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.709 0 0 0 0 0 0 0 0 0 394 876 439
2019/20205.949 353 349 383 671 490 924 662 492 550 471 330 274
2020/20214.488 366 266 392 259 377 395 445 256 400 409 378 545
2021/20224.330 262 297 252 373 268 237 302 297 190 303 801 748
2022/20235.585 550 449 176 511 475 1.233 459 382 591 190 296 273
2023/20242.533 381 465 236 216 279 428 162 236 35 95 0 0
Totale 33.559